Natera (NTRA) Capital Expenditures Growth (5y) (2019 - 2026)
Natera (NTRA) Capital Expenditures Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.63% |
| Dec 31, 2025 | 16.53% |
| Sep 30, 2025 | 38.32% |
| Jun 30, 2025 | 28.22% |
| Mar 31, 2025 | 52.36% |
| Dec 31, 2024 | 37.77% |
| Sep 30, 2024 | 44.90% |
| Jun 30, 2024 | 150.53% |
| Mar 31, 2024 | -10.86% |
| Dec 31, 2023 | 54.11% |
| Sep 30, 2023 | 75.18% |
| Jun 30, 2023 | 118.27% |
| Mar 31, 2023 | 13.62% |
| Dec 31, 2022 | 27.42% |
| Sep 30, 2022 | 99.12% |
| Jun 30, 2022 | -15.27% |
| Mar 31, 2022 | -19.85% |
| Dec 31, 2021 | 42.37% |
| Sep 30, 2021 | -48.28% |
| Jun 30, 2021 | -28.15% |